Form 8-K - Current report:
SEC Accession No. 0001185185-26-000010
Filing Date
2026-01-02
Accepted
2026-01-02 16:02:27
Documents
13
Period of Report
2025-12-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igc8k010226.htm   iXBRL 8-K 25014
2 GRAPHIC image_001.jpg GRAPHIC 5199
  Complete submission text file 0001185185-26-000010.txt   203305

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE igc-20251230.xsd EX-101.SCH 3010
4 XBRL LABEL FILE igc-20251230_lab.xml EX-101.LAB 34235
5 XBRL PRESENTATION FILE igc-20251230_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT igc8k010226_htm.xml XML 3187
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 26502327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)